Carpal tunnel syndrome (CTS) is a rare entity in children and usually has a different clinical presentation than in adults. The majority of these cases are related to a genetic condition. The most common aetiology is a lysosomal storage disease such as mucopolysaccharidoses or mucolipidoses (ML). Two siblings with bilateral median nerve neuropathy, wrist contractures and skeletal deformity on a background of mild facial coarsening and normal cognition are presented. There was a family history of similar complaints in first cousins. Nerve conduction studies were suggestive of bilateral median neuropathy with conduction block at the wrists. Biochemical investigation showed high levels of plasma lysosomal enzymes. Both patients underwent bilateral flexor retinaculum release. The findings at surgery were severe compression of the median nerve by the thickened flexor retinaculum. The histopathology of the thickened tissue showed a fibrosed and vascularised flexor retinaculum. On electron microscopy, macrophages with membrano-vacuolated inclusion zebra bodies were seen. Both patients had an uneventful recovery with symptomatic improvement. CTS is rarely seen in children except in association with genetic disorders. There is usually a delay in the diagnosis as attention is paid to the contractures rather than to the median nerve compression. The presence of CTS is typically seen in ML types II and III. Surgical intervention helps in improving the quality of life and hand function of these patients.

1.
Martin C, Masse P: Carpal tunnel syndrome in children (in French). Arch Fr Pediatr 1958;15:930-940.
2.
Van Meir N, De Smet L: Carpal tunnel syndrome in children. Acta Orthop Belg 2003;69:387-395.
3.
Poilvache P, Carlier A, Rombouts JJ, Partoune E, Lejeune G: Carpal tunnel syndrome in childhood: report of five new cases. J Pediatr Orthop 1989;9:687-690.
4.
Wraith JE: Mucopolysaccharidoses and mucolipidoses. Handb Clin Neurol 2013;113:1723-1729.
5.
Morishita K, Petty RE: Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology (Oxford) 2011;50(suppl 5):v19-v25.
6.
Gellis SS, Feingold M, Kelly TE: Picture of the month. Am J Dis Child 1975;129:1059-1060.
7.
Miner ME, Schimke RN: Carpal tunnel syndrome in pediatric mucopolysaccharidoses. Report of four cases. J Neurosurg 1975;43:102-103.
8.
Starreveld E, Ashenhurst EM: Bilateral carpal tunnel syndrome in childhood. A report of two sisters with mucolipidosis III (pseudo-Hurler polydystrophy). Neurology 1975;25:234-238.
9.
MacDougal B, Weeks PM, Wray RC Jr: Median nerve compression and trigger finger in the mucopolysaccharidoses and related diseases. Plast Reconstr Surg 1977;59:260-263.
10.
Haddad FS, Jones DH, Vellodi A, Kane N, Pitt MC: Carpal tunnel syndrome in the mucopolysaccharidoses and mucolipidoses. J Bone Joint Surg Br 1997;79:576-582.
11.
Wraith JE, Alani SM: Carpal tunnel syndrome in the mucopolysaccharidoses and related disorders. Arch Dis Child 1990;65:962-963.
12.
Meyer-Marcotty MV, Kollewe K, Dengler R, Grigull L, Altintas MA, Vogt PM: Carpal tunnel syndrome in children with mucopolysaccharidosis type 1H: diagnosis and therapy in an interdisciplinary centre (in German). Handchir Mikrochir Plast Chir 2012;44:23-28.
13.
al-Qattan MM, Thomson HG, Clarke HM: Carpal tunnel syndrome in children and adolescents with no history of trauma. J Hand Surg Br 1996;21:108-111.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.